Ocugen seeks USFDA nod for phase 3 trials of Covaxin

We are very excited to take this next step in the development of COVAXIN: Ocugen CEO

Comments

Popular posts from this blog

Viral video involving woman cop sparks controversy, plaint filed

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar